SAN FRANCISCO — A novel, noninvasive method was able to accurately and noninvasively identify clear cell renal carcinoma (ccRCC,), and shows promise for differentiating indeterminant renal masses, say researchers reporting the phase 3 ZIRCON study with radiolabeled 89Zr-DFO-girentuximab (TLX250-CDx, Telix). Detection of renal masses can present a considerable patient management challenge. Diagnostic options include cross-sectional imaging, which cannot reliably differentiate […]

Source: Read Full Article

When the ball dropped on New Year’s Eve to mark the beginning of 2023, I came to grips with the fact that I would turn 50 years old this year. Entering a new decade is often a time to pause and reflect on our lives, particularly when reaching middle age. For 50-year-old American men, the average remaining life expectancy is […]

Struggling with low mood and the pain of grief, Catherine Renton went to see her GP. He surprised her by delivering a prescription for time in nature. In a first-person piece for Processing, a Frame Of Mind series, she shares how this saved her life.  In February 2020, medicine from overseas I sat in my GP’s office and told him […]

Now Offers Patients the Choice of Administration at Home or in a Doctor’s Office THOUSAND OAKS, Calif., Feb. 2, propranolol esophagitis 2023 /PRNewswire/ — Amgen (NASDAQ:AMGN) and AstraZeneca today announced the U.S. Food and Drug Administration (FDA) has approved Tezspire® (tezepelumab-ekko) for self-administration in a pre-filled, single-use pen for patients aged 12 years and older with severe asthma.1 First approved […]

SAN FRANCISCO — Adding the PARP-inhibitor talazoparib (Talzenna, Pfizer) to treatment with the androgen pathway inhibitor enzalutamide (Xtandi, Astellas, Pfizer) significantly improved progression-free survival (PFS) in comparison with enzalutamide alone for patients with metastatic, castration-resistant prostate cancer (mCRPC) in the TALAPRO-2 trial. As determined on the basis of imaging, PFS was 37% better for talazoparib plus enzalutamide than for enzalutamide […]

Post-COVID-19 condition (PCC) is associated with a greater likelihood of unemployment and lower likelihood of working full time, according to a study published online Feb. 15 in JAMA Network Open. Roy H. Perlis, M.D., from Massachusetts General Hospital in Boston, and colleagues compared the prevalence of unemployment among individuals who did or did not develop PCC after acute infection. The […]

SAN FRANCISCO — For patients with metastatic castration-resistant prostate cancer (mCRPC) with a BRCA alteration whose disease had already progressed with an androgen receptor pathway inhibitor (ARPI), imaging-based progression-free survival (PFS) was significantly longer through treatment with rucaparib (Rubraca, Clovis) than with any other drug chosen by their physician. The finding, which comes from the TRITON3 clinical trial, stories of […]

As a patient with a family history of heart disease, Karen Moore has always been diligent about monitoring her heart health. When her primary care doctor heard something unusual during a routine examination, she sent Moore to cardiologist Mark Rabbat, MD, associate professor of medicine and radiology and director of cardiac computed tomography (CT) at Loyola Medicine. Her initial tests, […]

A person's personality and psychopathology levels may be associated with how strongly they prefer to focus on human faces within images, according to a study published in the open-access journal PLOS ONE by Marius Rubo from the University of Bern, Switzerland, seroquel used for aggression and colleagues. People tend to be drawn to other human faces when viewing images-;even visually-busy […]